Global Study Reveals Escalating Antimicrobial Resistance Patterns
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.
Category: Resource Center
Resource Center
Latest
Resource Center
Latest
HPV Self-Sampling Is Being Put into Practice in Texas
In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, of BD, returns to discuss BD and MD Anderson’s HPV self-collection study.
Resource Center
Latest
Abbott Survey Reveals Gaps in Pandemic Preparedness
Abbott's Pandemic Preparedness Survey found significant gaps remain in surveillance programs and testing infrastructure capabilities.
Genetic Testing on the Rise While Lab Testing Stays Stable
Avalon Healthcare Solutions’ Lab Trend Report found the use of genetic testing increased last year, while routine testing remained stable.
Read More
Minimally Invasive Blood Collection Boosts Participation of Homeless in Health Studies
A new study reveals that using minimally invasive blood collection devices can increase involvement of people experiencing homelessness.
Read More
Proximity to Cancer Center Contributes to Cancer Stage at Diagnosis
Location, race, and insurance status significantly affect whether cancer patients are diagnosed at an early or late stage.
Read MoreWebinar: Elevate Trauma Care with Advanced Coagulation Testing
Join our webinar to learn how aligning clinical and laboratory practices using the Quantra Hemostasis System can dramatically improve management of critical bleeding. Gain insights on viscoelastic testing, rapid identification of acute coagulopathy, and effective team collaboration. Perfect for technicians, lab managers, and healthcare providers.
Read More
Got Stress? It’s all About the Big Things
In a shift from talking about clinical diagnostics, this episode of Clinical Lab Chat focuses on how laboratory listeners can manage stress.
Read More
The Measles Outbreak: How Diagnostics Can Help Stem Infections
After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023.
Read More
What’s the Future of Robots and Clinical Labs?
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.
Read More
Is Blood Collection Poised for a Paradigm Shift?
In this episode of Clinical Lab Chat, CLP’s Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology.
Read More
UNC Lineberger Named a Research Hub for Cancer Screening Study
The newly launched Cancer Screening Research Network (CSRN) will evaluate promising and emerging cancer screening technologies.
Read More
How Menstrual Blood Is Being Transformed Into a Diagnostic Tool
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read More
PanGIA Biotech to Expand Multi-Cancer Early Detection Liquid Biopsy Study
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More
Age Significantly Impacts Bleeding Disorder Diagnosis
This research could help address challenges in misdiagnosis and treatment of patients, potentially reducing bleeding complication risks.
Read More
How Omics Technology Bolsters Precision Medicine
In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.
Read More
A New Non-Invasive Breast Cancer Diagnostic Test
CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include using urine to identify breast cancer biomarkers; the distinctions between mammographies and liquid biopsies for cancer detection; and more.
Read More
The State of Allergy Testing
Discover the latest insights on food allergies in the U.S. on Clinical Lab Chat! Join Chris Wolski, CLP’s Director of Business Intelligence, in a conversation with Jessica Murphy, MLS(ASCP)CM, from Thermo Fisher Scientific. They delve into:
The surge in food allergies among Americans and its causes.
The game-changing impact of home testing on allergy detection (and its challenges).
The crucial role of primary care doctors in allergy testing.
The promise of precise allergy testing for better patient care.
Why clinical labs remain vital for allergy diagnostics.
A glimpse into the future of allergy testing in the next 5-10 years. Don’t miss it!
